1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pharmaceutical CDMO Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Drug Substance Development and Manufacturing 1.2.3 Specialized Services 1.2.4 Lab-based Services 1.3 Market by Application 1.3.1 Global Pharmaceutical CDMO Services Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Innovative Medicine 1.3.3 Patented Drug 1.3.4 Patent Expired Drug 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pharmaceutical CDMO Services Market Perspective (2016-2027) 2.2 Pharmaceutical CDMO Services Growth Trends by Regions 2.2.1 Pharmaceutical CDMO Services Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Pharmaceutical CDMO Services Historic Market Share by Regions (2016-2021) 2.2.3 Pharmaceutical CDMO Services Forecasted Market Size by Regions (2022-2027) 2.3 Pharmaceutical CDMO Services Industry Dynamic 2.3.1 Pharmaceutical CDMO Services Market Trends 2.3.2 Pharmaceutical CDMO Services Market Drivers 2.3.3 Pharmaceutical CDMO Services Market Challenges 2.3.4 Pharmaceutical CDMO Services Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pharmaceutical CDMO Services Players by Revenue 3.1.1 Global Top Pharmaceutical CDMO Services Players by Revenue (2016-2021) 3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by Players (2016-2021) 3.2 Global Pharmaceutical CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Pharmaceutical CDMO Services Revenue 3.4 Global Pharmaceutical CDMO Services Market Concentration Ratio 3.4.1 Global Pharmaceutical CDMO Services Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO Services Revenue in 2020 3.5 Pharmaceutical CDMO Services Key Players Head office and Area Served 3.6 Key Players Pharmaceutical CDMO Services Product Solution and Service 3.7 Date of Enter into Pharmaceutical CDMO Services Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pharmaceutical CDMO Services Breakdown Data by Type 4.1 Global Pharmaceutical CDMO Services Historic Market Size by Type (2016-2021) 4.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2022-2027) 5 Pharmaceutical CDMO Services Breakdown Data by Application 5.1 Global Pharmaceutical CDMO Services Historic Market Size by Application (2016-2021) 5.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Pharmaceutical CDMO Services Market Size (2016-2027) 6.2 North America Pharmaceutical CDMO Services Market Size by Type 6.2.1 North America Pharmaceutical CDMO Services Market Size by Type (2016-2021) 6.2.2 North America Pharmaceutical CDMO Services Market Size by Type (2022-2027) 6.2.3 North America Pharmaceutical CDMO Services Market Size by Type (2016-2027) 6.3 North America Pharmaceutical CDMO Services Market Size by Application 6.3.1 North America Pharmaceutical CDMO Services Market Size by Application (2016-2021) 6.3.2 North America Pharmaceutical CDMO Services Market Size by Application (2022-2027) 6.3.3 North America Pharmaceutical CDMO Services Market Size by Application (2016-2027) 6.4 North America Pharmaceutical CDMO Services Market Size by Country 6.4.1 North America Pharmaceutical CDMO Services Market Size by Country (2016-2021) 6.4.2 North America Pharmaceutical CDMO Services Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Pharmaceutical CDMO Services Market Size (2016-2027) 7.2 Europe Pharmaceutical CDMO Services Market Size by Type 7.2.1 Europe Pharmaceutical CDMO Services Market Size by Type (2016-2021) 7.2.2 Europe Pharmaceutical CDMO Services Market Size by Type (2022-2027) 7.2.3 Europe Pharmaceutical CDMO Services Market Size by Type (2016-2027) 7.3 Europe Pharmaceutical CDMO Services Market Size by Application 7.3.1 Europe Pharmaceutical CDMO Services Market Size by Application (2016-2021) 7.3.2 Europe Pharmaceutical CDMO Services Market Size by Application (2022-2027) 7.3.3 Europe Pharmaceutical CDMO Services Market Size by Application (2016-2027) 7.4 Europe Pharmaceutical CDMO Services Market Size by Country 7.4.1 Europe Pharmaceutical CDMO Services Market Size by Country (2016-2021) 7.4.2 Europe Pharmaceutical CDMO Services Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Pharmaceutical CDMO Services Market Size (2016-2027) 8.2 Asia-Pacific Pharmaceutical CDMO Services Market Size by Type 8.2.1 Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2016-2027) 8.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Application 8.3.1 Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2016-2027) 8.4 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region 8.4.1 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pharmaceutical CDMO Services Market Size (2016-2027) 9.2 Latin America Pharmaceutical CDMO Services Market Size by Type 9.2.1 Latin America Pharmaceutical CDMO Services Market Size by Type (2016-2021) 9.2.2 Latin America Pharmaceutical CDMO Services Market Size by Type (2022-2027) 9.2.3 Latin America Pharmaceutical CDMO Services Market Size by Type (2016-2027) 9.3 Latin America Pharmaceutical CDMO Services Market Size by Application 9.3.1 Latin America Pharmaceutical CDMO Services Market Size by Application (2016-2021) 9.3.2 Latin America Pharmaceutical CDMO Services Market Size by Application (2022-2027) 9.3.3 Latin America Pharmaceutical CDMO Services Market Size by Application (2016-2027) 9.4 Latin America Pharmaceutical CDMO Services Market Size by Country 9.4.1 Latin America Pharmaceutical CDMO Services Market Size by Country (2016-2021) 9.4.2 Latin America Pharmaceutical CDMO Services Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pharmaceutical CDMO Services Market Size (2016-2027) 10.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type 10.2.1 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2016-2027) 10.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application 10.3.1 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2016-2027) 10.4 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country 10.4.1 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Recipharm AB 11.1.1 Recipharm AB Company Details 11.1.2 Recipharm AB Business Overview 11.1.3 Recipharm AB Pharmaceutical CDMO Services Introduction 11.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2016-2021) 11.1.5 Recipharm AB Recent Development 11.2 AMRI Global 11.2.1 AMRI Global Company Details 11.2.2 AMRI Global Business Overview 11.2.3 AMRI Global Pharmaceutical CDMO Services Introduction 11.2.4 AMRI Global Revenue in Pharmaceutical CDMO Services Business (2016-2021) 11.2.5 AMRI Global Recent Development 11.3 Patheon N.V. 11.3.1 Patheon N.V. Company Details 11.3.2 Patheon N.V. Business Overview 11.3.3 Patheon N.V. Pharmaceutical CDMO Services Introduction 11.3.4 Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2016-2021) 11.3.5 Patheon N.V. Recent Development 11.4 Aenova Group 11.4.1 Aenova Group Company Details 11.4.2 Aenova Group Business Overview 11.4.3 Aenova Group Pharmaceutical CDMO Services Introduction 11.4.4 Aenova Group Revenue in Pharmaceutical CDMO Services Business (2016-2021) 11.4.5 Aenova Group Recent Development 11.5 Catalent, Inc. 11.5.1 Catalent, Inc. Company Details 11.5.2 Catalent, Inc. Business Overview 11.5.3 Catalent, Inc. Pharmaceutical CDMO Services Introduction 11.5.4 Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2016-2021) 11.5.5 Catalent, Inc. Recent Development 11.6 Amatsigroup 11.6.1 Amatsigroup Company Details 11.6.2 Amatsigroup Business Overview 11.6.3 Amatsigroup Pharmaceutical CDMO Services Introduction 11.6.4 Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2016-2021) 11.6.5 Amatsigroup Recent Development 11.7 WuXi AppTec Group 11.7.1 WuXi AppTec Group Company Details 11.7.2 WuXi AppTec Group Business Overview 11.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Introduction 11.7.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2016-2021) 11.7.5 WuXi AppTec Group Recent Development 11.8 Strides Pharma Science Limited 11.8.1 Strides Pharma Science Limited Company Details 11.8.2 Strides Pharma Science Limited Business Overview 11.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Introduction 11.8.4 Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2016-2021) 11.8.5 Strides Pharma Science Limited Recent Development 11.9 Piramal Pharma Solutions 11.9.1 Piramal Pharma Solutions Company Details 11.9.2 Piramal Pharma Solutions Business Overview 11.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Introduction 11.9.4 Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2016-2021) 11.9.5 Piramal Pharma Solutions Recent Development 11.10 Siegfried Ltd 11.10.1 Siegfried Ltd Company Details 11.10.2 Siegfried Ltd Business Overview 11.10.3 Siegfried Ltd Pharmaceutical CDMO Services Introduction 11.10.4 Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2016-2021) 11.10.5 Siegfried Ltd Recent Development 11.11 Fareva Group 11.11.1 Fareva Group Company Details 11.11.2 Fareva Group Business Overview 11.11.3 Fareva Group Pharmaceutical CDMO Services Introduction 11.11.4 Fareva Group Revenue in Pharmaceutical CDMO Services Business (2016-2021) 11.11.5 Fareva Group Recent Development 11.12 FAMAR Health Care Services 11.12.1 FAMAR Health Care Services Company Details 11.12.2 FAMAR Health Care Services Business Overview 11.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Introduction 11.12.4 FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2016-2021) 11.12.5 FAMAR Health Care Services Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pharmaceutical CDMO Services Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Drug Substance Development and Manufacturing Table 3. Key Players of Specialized Services Table 4. Key Players of Lab-based Services Table 5. Global Pharmaceutical CDMO Services Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Pharmaceutical CDMO Services Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Pharmaceutical CDMO Services Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Pharmaceutical CDMO Services Market Share by Regions (2016-2021) Table 9. Global Pharmaceutical CDMO Services Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Pharmaceutical CDMO Services Market Share by Regions (2022-2027) Table 11. Pharmaceutical CDMO Services Market Trends Table 12. Pharmaceutical CDMO Services Market Drivers Table 13. Pharmaceutical CDMO Services Market Challenges Table 14. Pharmaceutical CDMO Services Market Restraints Table 15. Global Pharmaceutical CDMO Services Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Pharmaceutical CDMO Services Market Share by Players (2016-2021) Table 17. Global Top Pharmaceutical CDMO Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical CDMO Services as of 2020) Table 18. Ranking of Global Top Pharmaceutical CDMO Services Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Pharmaceutical CDMO Services Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Pharmaceutical CDMO Services Product Solution and Service Table 22. Date of Enter into Pharmaceutical CDMO Services Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Pharmaceutical CDMO Services Market Size by Type (2016-2021) (US$ Million) Table 25. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2016-2021) Table 26. Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Pharmaceutical CDMO Services Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Pharmaceutical CDMO Services Revenue Market Share by Application (2016-2021) Table 30. Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Pharmaceutical CDMO Services Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Pharmaceutical CDMO Services Market Size by Type (2016-2021) (US$ Million) Table 33. North America Pharmaceutical CDMO Services Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Pharmaceutical CDMO Services Market Size by Application (2016-2021) (US$ Million) Table 35. North America Pharmaceutical CDMO Services Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Pharmaceutical CDMO Services Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Pharmaceutical CDMO Services Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Pharmaceutical CDMO Services Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Pharmaceutical CDMO Services Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Pharmaceutical CDMO Services Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Pharmaceutical CDMO Services Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Pharmaceutical CDMO Services Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Pharmaceutical CDMO Services Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Pharmaceutical CDMO Services Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Pharmaceutical CDMO Services Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Pharmaceutical CDMO Services Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Pharmaceutical CDMO Services Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Pharmaceutical CDMO Services Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Pharmaceutical CDMO Services Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2022-2027) & (US$ Million) Table 62. Recipharm AB Company Details Table 63. Recipharm AB Business Overview Table 64. Recipharm AB Pharmaceutical CDMO Services Product Table 65. Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million) Table 66. Recipharm AB Recent Development Table 67. AMRI Global Company Details Table 68. AMRI Global Business Overview Table 69. AMRI Global Pharmaceutical CDMO Services Product Table 70. AMRI Global Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million) Table 71. AMRI Global Recent Development Table 72. Patheon N.V. Company Details Table 73. Patheon N.V. Business Overview Table 74. Patheon N.V. Pharmaceutical CDMO Services Product Table 75. Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million) Table 76. Patheon N.V. Recent Development Table 77. Aenova Group Company Details Table 78. Aenova Group Business Overview Table 79. Aenova Group Pharmaceutical CDMO Services Product Table 80. Aenova Group Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million) Table 81. Aenova Group Recent Development Table 82. Catalent, Inc. Company Details Table 83. Catalent, Inc. Business Overview Table 84. Catalent, Inc. Pharmaceutical CDMO Services Product Table 85. Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million) Table 86. Catalent, Inc. Recent Development Table 87. Amatsigroup Company Details Table 88. Amatsigroup Business Overview Table 89. Amatsigroup Pharmaceutical CDMO Services Product Table 90. Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million) Table 91. Amatsigroup Recent Development Table 92. WuXi AppTec Group Company Details Table 93. WuXi AppTec Group Business Overview Table 94. WuXi AppTec Group Pharmaceutical CDMO Services Product Table 95. WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million) Table 96. WuXi AppTec Group Recent Development Table 97. Strides Pharma Science Limited Company Details Table 98. Strides Pharma Science Limited Business Overview Table 99. Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million) Table 100. Strides Pharma Science Limited Recent Development Table 101. Piramal Pharma Solutions Company Details Table 102. Piramal Pharma Solutions Business Overview Table 103. Piramal Pharma Solutions Pharmaceutical CDMO Services Product Table 104. Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million) Table 105. Piramal Pharma Solutions Recent Development Table 106. Siegfried Ltd Company Details Table 107. Siegfried Ltd Business Overview Table 108. Siegfried Ltd Pharmaceutical CDMO Services Product Table 109. Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million) Table 110. Siegfried Ltd Recent Development Table 111. Fareva Group Company Details Table 112. Fareva Group Business Overview Table 113. Fareva Group Pharmaceutical CDMO Services Product Table 114. Fareva Group Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million) Table 115. Fareva Group Recent Development Table 116. FAMAR Health Care Services Company Details Table 117. FAMAR Health Care Services Business Overview Table 118. FAMAR Health Care Services Pharmaceutical CDMO Services Product Table 119. FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million) Table 120. FAMAR Health Care Services Recent Development Table 121. Research Programs/Design for This Report Table 122. Key Data Information from Secondary Sources Table 123. Key Data Information from Primary Sources List of Figures Figure 1. Global Pharmaceutical CDMO Services Market Share by Type: 2020 VS 2027 Figure 2. Drug Substance Development and Manufacturing Features Figure 3. Specialized Services Features Figure 4. Lab-based Services Features Figure 5. Global Pharmaceutical CDMO Services Market Share by Application: 2020 VS 2027 Figure 6. Innovative Medicine Case Studies Figure 7. Patented Drug Case Studies Figure 8. Patent Expired Drug Case Studies Figure 9. Pharmaceutical CDMO Services Report Years Considered Figure 10. Global Pharmaceutical CDMO Services Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Pharmaceutical CDMO Services Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Pharmaceutical CDMO Services Market Share by Regions: 2020 VS 2027 Figure 13. Global Pharmaceutical CDMO Services Market Share by Regions (2022-2027) Figure 14. Global Pharmaceutical CDMO Services Market Share by Players in 2020 Figure 15. Global Top Pharmaceutical CDMO Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical CDMO Services as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical CDMO Services Revenue in 2020 Figure 17. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2016-2021) Figure 18. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2022-2027) Figure 19. North America Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Pharmaceutical CDMO Services Market Share by Type (2016-2027) Figure 21. North America Pharmaceutical CDMO Services Market Share by Application (2016-2027) Figure 22. North America Pharmaceutical CDMO Services Market Share by Country (2016-2027) Figure 23. United States Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Pharmaceutical CDMO Services Market Share by Type (2016-2027) Figure 27. Europe Pharmaceutical CDMO Services Market Share by Application (2016-2027) Figure 28. Europe Pharmaceutical CDMO Services Market Share by Country (2016-2027) Figure 29. Germany Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Pharmaceutical CDMO Services Market Share by Type (2016-2027) Figure 37. Asia-Pacific Pharmaceutical CDMO Services Market Share by Application (2016-2027) Figure 38. Asia-Pacific Pharmaceutical CDMO Services Market Share by Region (2016-2027) Figure 39. China Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Pharmaceutical CDMO Services Market Share by Type (2016-2027) Figure 47. Latin America Pharmaceutical CDMO Services Market Share by Application (2016-2027) Figure 48. Latin America Pharmaceutical CDMO Services Market Share by Country (2016-2027) Figure 49. Mexico Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Pharmaceutical CDMO Services Market Share by Type (2016-2027) Figure 53. Middle East & Africa Pharmaceutical CDMO Services Market Share by Application (2016-2027) Figure 54. Middle East & Africa Pharmaceutical CDMO Services Market Share by Country (2016-2027) Figure 55. Turkey Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021) Figure 59. AMRI Global Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021) Figure 60. Patheon N.V. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021) Figure 61. Aenova Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021) Figure 62. Catalent, Inc. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021) Figure 63. Amatsigroup Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021) Figure 64. WuXi AppTec Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021) Figure 65. Strides Pharma Science Limited Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021) Figure 66. Piramal Pharma Solutions Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021) Figure 67. Siegfried Ltd Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021) Figure 68. Fareva Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021) Figure 69. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Recipharm AB AMRI Global Patheon N.V. Aenova Group Catalent, Inc. Amatsigroup WuXi AppTec Group Strides Pharma Science Limited Piramal Pharma Solutions Siegfried Ltd Fareva Group FAMAR Health Care Services